Sofosbuvir and Visual acuity reduced - a phase IV clinical study of FDA data

Summary:

Visual acuity reduced is reported as a side effect among people who take Sofosbuvir (sofosbuvir), especially for people who are male, 40-49 old, have been taking the drug for 1 - 6 months also take Etravirine, and have Hiv infection.

The phase IV clinical study analyzes which people have Visual acuity reduced when taking Sofosbuvir. It is created by eHealthMe based on reports of 9,193 people who have side effects when taking Sofosbuvir from the FDA, and is updated regularly.

What is Sofosbuvir?

Sofosbuvir has active ingredients of sofosbuvir. eHealthMe is studying from 9,194 Sofosbuvir users. Check the latest studies of Sofosbuvir.

What is Visual acuity reduced?

Visual acuity reduced (reduced clearness of vision) is found to be associated with 1,492 drugs and 1,887 conditions by eHealthMe. Check the latest studies of Visual acuity reduced.

On Jul, 16, 2026

9,193 people reported to have side effects when taking Sofosbuvir.
Among them, 17 people (0.18%) have Visual acuity reduced.

Could Sofosbuvir cause Visual acuity reduced?

Among these 17 people:

How long have people been on Sofosbuvir when they have Visual acuity reduced? *

What is the gender of people who have Visual acuity reduced when taking Sofosbuvir? *

female: 43.75 %
male: 56.25 %

What is the age of people who have Visual acuity reduced when taking Sofosbuvir? *

What are other drugs people take besides Sofosbuvir? *

What are other side effects people have besides Visual acuity reduced? *

Hair Loss: 7 people, 41.18%
Influenza Like Illness: 6 people, 35.29%
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets): 6 people, 35.29%
Vision Blurred: 6 people, 35.29%
General Physical Health Deterioration (weak health status): 5 people, 29.41%
Leukopenia (less number of white blood cells in blood): 5 people, 29.41%
Anaemia (lack of blood): 5 people, 29.41%
Thrombocytopenia (decrease of platelets in blood): 5 people, 29.41%
Uveitis (inflammation of the uvea): 5 people, 29.41%
Fatigue (feeling of tiredness): 3 people, 17.65%

What are the existing conditions these people have? *

Hiv Infection: 5 people, 29.41%
Hepatitis C: 4 people, 23.53%
Barrett's Oesophagus (barrett's oesophagus is a disorder in which the lining of the oesophagus (the tube that carries food from the throat to the stomach) is damaged by stomach acid and changed to a lining similar to that of the stomach): 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Sofosbuvir and have Visual acuity reduced?

- Check whether Visual acuity reduced is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Sofosbuvir:

Sofosbuvir (9,194 reports)

Browse all side effects of Sofosbuvir:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Visual acuity reduced:

Visual acuity reduced (1,492 drugs)

Browse all the conditions that are associated with Visual acuity reduced:

Visual acuity reduced (1,887 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on sofosbuvir (the active ingredients of Sofosbuvir) and Sofosbuvir (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.